Richmonde Advisory Signs MOU with Dr. Kampon Sriwatanakul
On July 13, 2024, Richmonde Advisory Co. Ltd. signed a Memorandum of Understanding (MOU) with Dr. Kampon Sriwatanakul, marking the beginning of a strategic partnership aimed at enhancing the legal and business framework supporting the Thailand Charter of Health. The MOU was signed by Mr. Sarawut Ruamsamak, Managing Director of Richmonde Advisory.
Background and Expertise
Richmonde Advisory is renowned for its extensive network and expertise in legal consultancy, mergers and acquisitions (M&A), corporate litigation, and corporate secretarial services. With a team of highly skilled legal professionals and strategic partnerships across finance, accounting, and government affairs, Richmonde Advisory is well-positioned to offer comprehensive legal support. This partnership reinforces Richmonde’s commitment to providing top-tier legal services and fostering business connections in the healthcare and wellness sectors.
Supporting the Thailand Charter of Health
The collaboration between Richmonde Advisory and Dr. Kampon aims to strengthen the Thailand Charter of Health’s position as a leading research foundation. By leveraging Richmonde’s legal expertise, the partnership will support the Charter’s mission of advancing medical and health research, innovative medicine, and holistic wellness.
About the Thailand Charter of Health
The Thailand Charter of Health is a prominent research foundation dedicated to pioneering studies in medical science, health, innovative medicine, and holistic wellness. The organization is also deeply involved in wellness tourism and collaborates with international communities on scientific research initiatives. Under the leadership of Dr. Kampon Sriwatanakul, the Charter is committed to fostering a multidisciplinary approach to health and wellness.
The expert committee of the Thailand Charter of Health comprises various reputable individuals from the fields of biopharmaceuticals, wellness tourism, and non-communicable disease (NCD) research. Notably, Dr. Pongrama Ramasoota serves as a Collaborative Professor at Osaka University and Associate Professor in the Department of Social and Environmental Medicine at Mahidol University. With extensive qualifications, including a Doctor of Veterinary Medicine degree from Kasetsart University, a Master of Public Health from Mahidol University, and advanced degrees in Microbiology from the Swedish University of Agricultural Science, Dr. Pongrama leads a team of researchers at the Center of Excellence for Antibody Research (CEAR) and teaches at the Bangkok School of Tropical Medicine.
Dr. Pongrama specializes in the characterization and production of therapeutic human monoclonal antibodies against dengue virus. He led the development of a neutralizing human monoclonal antibody with 96-100% efficacy against all dengue virus serotypes. His research also includes DNA vaccine development for dengue and canine parvovirus, and improved diagnostic tests for dengue, tuberculosis, and foot-and-mouth disease virus.
Conclusion
The MOU between Richmonde Advisory and Dr. Kampon Sriwatanakul signifies a major step forward in enhancing the legal and organizational strength of the Thailand Charter of Health. This partnership is expected to drive significant advancements in medical research, health promotion, and wellness tourism, positioning Thailand as a global leader in these fields.
Article by Adisorn V. Ping